Starpharma with Proactive at the ASX Small and Mid-Cap Conference

News Direct

Mar 22, 2023

–News Direct–

Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The company is focused on the development of pharmaceutical and medical products for unmet patient needs, including in the areas of oncology and infectious diseases.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

jonathan@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/starpharma-with-proactive-at-the-asx-small-and-mid-cap-conference-595383537

YOU MAY ALSO LIKE

Steppe Gold Announces Shareholder Vote Date for…

--News Direct--Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The…

read more

Ideal Power Advances with New Semiconductor Technology…

--News Direct--Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The…

read more

Delivra Health Brands releases Q3 financial number…

--News Direct--Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The…

read more